These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Lack of heritability of exhaled volatile compound pattern: an electronic nose twin study. Tarnoki DL; Bikov A; Tarnoki AD; Lazar Z; Szilagyi BK; Korosi BZ; Horvath T; Littvay L; Losonczy G; Horvath I J Breath Res; 2014 Mar; 8(1):016001. PubMed ID: 24421262 [TBL] [Abstract][Full Text] [Related]
7. Established methodological issues in electronic nose research: how far are we from using these instruments in clinical settings of breath analysis? Bikov A; Lázár Z; Horvath I J Breath Res; 2015 Jun; 9(3):034001. PubMed ID: 26056127 [TBL] [Abstract][Full Text] [Related]
8. Short-Term Effect of Cigarette Smoke on Exhaled Volatile Organic Compounds Profile Analyzed by an Electronic Nose. Dragonieri S; Quaranta VN; Buonamico E; Battisti C; Ranieri T; Carratu P; Carpagnano GE Biosensors (Basel); 2022 Jul; 12(7):. PubMed ID: 35884323 [TBL] [Abstract][Full Text] [Related]
9. Exhaled breath profiling by electronic nose enabled discrimination of allergic rhinitis and extrinsic asthma. Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O Biomarkers; 2019 Feb; 24(1):70-75. PubMed ID: 30074408 [TBL] [Abstract][Full Text] [Related]
10. Influence of age and gender on the profile of exhaled volatile organic compounds analyzed by an electronic nose. Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O J Bras Pneumol; 2016 Apr; 42(2):143-5. PubMed ID: 27167436 [TBL] [Abstract][Full Text] [Related]
11. Exhaled breath profiling in patients with COPD and OSA overlap syndrome: a pilot study. Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O J Breath Res; 2016 Nov; 10(4):041001. PubMed ID: 27811380 [TBL] [Abstract][Full Text] [Related]
12. Electronic nose based analysis of exhaled volatile organic compounds spectrum reveals asthmatic shifts and consistency in controls post-exercise and spirometry. Dragonieri S; Marco MD; Ahroud M; Quaranta VN; Portacci A; Iorillo I; Montagnolo F; Carpagnano GE J Breath Res; 2024 Jun; 18(3):. PubMed ID: 38876093 [TBL] [Abstract][Full Text] [Related]
13. Identification of profiles of volatile organic compounds in exhaled breath by means of an electronic nose as a proposal for a screening method for breast cancer: a case-control study. Díaz de León-Martínez L; Rodríguez-Aguilar M; Gorocica-Rosete P; Domínguez-Reyes CA; Martínez-Bustos V; Tenorio-Torres JA; Ornelas-Rebolledo O; Cruz-Ramos JA; Balderas-Segura B; Flores-Ramírez R J Breath Res; 2020 Sep; 14(4):046009. PubMed ID: 32698165 [TBL] [Abstract][Full Text] [Related]
14. An electronic nose in the discrimination of obese patients with and without obstructive sleep apnoea. Dragonieri S; Porcelli F; Longobardi F; Carratù P; Aliani M; Ventura VA; Tutino M; Quaranta VN; Resta O; de Gennaro G J Breath Res; 2015 Apr; 9(2):026005. PubMed ID: 25891965 [TBL] [Abstract][Full Text] [Related]
15. Expiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer. Bikov A; Hernadi M; Korosi BZ; Kunos L; Zsamboki G; Sutto Z; Tarnoki AD; Tarnoki DL; Losonczy G; Horvath I BMC Pulm Med; 2014 Dec; 14():202. PubMed ID: 25510554 [TBL] [Abstract][Full Text] [Related]
16. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643 [TBL] [Abstract][Full Text] [Related]
17. Validation of exhaled volatile organic compounds analysis using electronic nose as index of COPD severity. Finamore P; Pedone C; Scarlata S; Di Paolo A; Grasso S; Santonico M; Pennazza G; Antonelli Incalzi R Int J Chron Obstruct Pulmon Dis; 2018; 13():1441-1448. PubMed ID: 29750030 [TBL] [Abstract][Full Text] [Related]